[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100624153":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":35,"centralContacts":55,"locations":65,"responsibleParty":127,"collaborators":130,"id":136,"slug":137,"hasResults":138,"nctId":139,"briefTitle":140,"officialTitle":140,"acronym":12,"eligibilityCriteria":141,"healthyVolunteers":138,"sex":142,"minAge":143,"maxAge":12,"enrollmentInfo":144,"targetDuration":12,"studyType":147,"phases":148,"briefSummary":150,"conditions":151,"keywords":12,"overallStatus":67,"whyStopped":12,"lastUpdateSubmitDate":160,"lastUpdatePostDateStruct":161,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":169},{"fullName":5,"class":6},"Ulsan University Hospital","OTHER",[8,13,19],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard Care Group","NO_INTERVENTION","Standard care group is the control group, receiving standard care only without using Smart Cancer Care Plus or standardized telenursing.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"ePRO Group","EXPERIMENTAL","ePRO group is the experimental group, using Smart Cancer Care Plus without standardized telenursing.",[18],"Other: Smart Cancer Care Plus",{"label":20,"type":15,"description":21,"interventionNames":22},"ePRO + Telenursing Group","ePRO + Telenursing group is the experimental group, using Smart Cancer Care Plus in combination with standardized telenursing.",[23,18],"Other: Standardized Telenursing",[25,29],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":12},"Standardized Telenursing","Within Smart Cancer Care Plus, predefined criteria are applied to trigger standardized telenursing interventions. When patients report symptoms of Grade 3 or higher severity, or when a scheduled weekly symptom report is not submitted within 48 hours of the designated reporting date, a structured telephone counseling session is initiated. This process is intended to ensure timely clinical follow-up, support appropriate self-management, and prevent the progression of unmanaged adverse events.",[20],{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Smart Cancer Care Plus","Smart Cancer Care Plus is a digital platform for patient-reported symptom monitoring and management, developed for individuals receiving chemotherapy. The system enables structured reporting of chemotherapy-related adverse events and provides standardized information regarding the severity grading of symptoms, accompanied by evidence-based self-management strategies. This intervention is intended to promote systematic symptom monitoring and to facilitate timely clinical responses to adverse events.",[20,14],[34],"Smart Caner Care Plus",[36,39,42,44,46,49,52],{"name":37,"affiliation":5,"role":38},"Sujin Koh, Doctor of Philoshophy","PRINCIPAL_INVESTIGATOR",{"name":40,"affiliation":41,"role":38},"Keun Soek Lee, Doctor of Philoshophy","National Cancer Center, Korea",{"name":43,"affiliation":41,"role":38},"Sung Hoon Sim, Doctor of Philoshophy",{"name":45,"affiliation":41,"role":38},"Ji Hyung Hong, Doctor of Philoshophy",{"name":47,"affiliation":48,"role":38},"Sun Jin Sym, Doctor of Philoshophy","Gachon University Gil Medical Center",{"name":50,"affiliation":51,"role":38},"Jung Hun Kang, Doctor of Philoshophy","Gyeongsang National University Hospital",{"name":53,"affiliation":54,"role":38},"Seong Hoon Shin, Doctor of Philoshophy","Kosin University Gospel Hospital",[56,61],{"name":57,"role":58,"phone":59,"phoneExt":12,"email":60},"Minseon Song, bachelor's degree","CONTACT","+82522507018","9204564@uuh.ulsan.kr",{"name":62,"role":58,"phone":63,"phoneExt":12,"email":64},"Somin Joen, bachelor's degree","+82522301417","9204648@uuh.ulsan.kr",[66,81,92,105,117],{"facility":54,"status":67,"city":68,"state":12,"zip":12,"country":69,"countryCode":12,"cosmosGeoPoint":70,"geoPoint":75,"contacts":76},"RECRUITING","Busan","South Korea",{"type":71,"coordinates":72},"Point",[73,74],129.03004,35.10168,{"lat":74,"lon":73},[77],{"name":78,"role":58,"phone":79,"phoneExt":12,"email":80},"Kim","+8210-6227-6721","kimeunji514@naver.com",{"facility":41,"status":67,"city":82,"state":12,"zip":12,"country":69,"countryCode":12,"cosmosGeoPoint":83,"geoPoint":87,"contacts":88},"Goyang",{"type":71,"coordinates":84},[85,86],127.19731,36.21689,{"lat":86,"lon":85},[89],{"name":78,"role":58,"phone":90,"phoneExt":12,"email":91},"+8210-9050-4257","bst7978@ncc.re.kr",{"facility":48,"status":93,"city":94,"state":12,"zip":12,"country":69,"countryCode":12,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"NOT_YET_RECRUITING","Incheon",{"type":71,"coordinates":96},[97,98],126.70515,37.45646,{"lat":98,"lon":97},[101],{"name":102,"role":58,"phone":103,"phoneExt":12,"email":104},"Choi","+8210-9271-7739","hihi7739@naver.com",{"facility":106,"status":67,"city":107,"state":12,"zip":12,"country":69,"countryCode":12,"cosmosGeoPoint":108,"geoPoint":112,"contacts":113},"Gyeongsang National University","Jinju",{"type":71,"coordinates":109},[110,111],128.08472,35.19278,{"lat":111,"lon":110},[114],{"name":78,"role":58,"phone":115,"phoneExt":12,"email":116},"+8210-3533-0595","mamagirl75@hanmail.net",{"facility":5,"status":67,"city":118,"state":12,"zip":12,"country":69,"countryCode":12,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"Ulsan",{"type":71,"coordinates":120},[121,122],129.31667,35.53722,{"lat":122,"lon":121},[125],{"name":126,"role":58,"phone":59,"phoneExt":12,"email":60},"Song",{"type":38,"investigatorFullName":128,"investigatorTitle":129,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Koh Su-Jin","Professor",[131,133,134,135],{"name":41,"class":132},"OTHER_GOV",{"name":54,"class":6},{"name":51,"class":6},{"name":48,"class":6},"100624153","evaluation-of-the-effectiveness-of-managing-chemotherapy-side-effects-using-epro-and-a-standardized-telenursing-program-for-cancer-patients-100624153",false,"NCT07405931","Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients","Inclusion Criteria:\n\n* Adults aged 19 years or older\n* Diagnosed with early or advanced gastric, lung, breast, or colon cancer\n* Starting first-cycle chemotherapy with a new anticancer agent\n* Able to use a smartphone without difficulty\n* Willing to provide informed consent to participate in the study\n\nExclusion Criteria:\n\n* Individuals who have difficulty communicating due to cognitive impairment, visual impairment, hearing impairment, or other reasons\n* Individuals who cannot read, write, or understand Korean\n* Other individuals deemed inappropriate for participation by the investigators","ALL","19 Years",{"count":145,"type":146},414,"ESTIMATED","INTERVENTIONAL",[149],"NA","This is a multicenter randomized controlled clinical trial designed to evaluate the clinical efficacy and cost-effectiveness of a digital health platform that integrates a symptom reporting and management software with a standardized telenursing program, allowing cancer patients to actively monitor, report, and self-manage chemotherapy-related adverse effects.",[152,153,154,155,156,157,158,159],"Early Gastric Cancer","Advanced Gastric Cancer","Early Lung Cancer","Advanced Lung Cancer","Early Breast Cancer","Advanced Breast Cancer","Early Colon Cancer","Advanced Colon Cancer","2026-02-08",{"date":162,"type":163},"2026-02-12","ACTUAL",{"date":165,"type":163},"2025-07-09",{"date":167,"type":146},"2026-09",{"name":5,"class":6},5]